| Patents for C07K 17 - Carrier-bound or immobilised peptides; Preparation thereof (10,673) |
|---|
| 04/29/2004 | US20040082758 Immune reactivity to HER-2/neu protein for diagnosis and treatment of malignancies in which the HER-2/neu oncogene is associated |
| 04/28/2004 | EP1412517A2 Methods, kits and compositions of combination oligomers |
| 04/28/2004 | CN1492926A Preferred segments of neural thread protein and methods of using the same |
| 04/22/2004 | WO2004033488A2 Peptide mediated synthesis of metallic and magnetic materials |
| 04/22/2004 | WO2004032839A2 Methods and formulations comprising agonists and antagonists of nuclear hormone receptors |
| 04/22/2004 | US20040077541 Methods of using non-human animal Apolipoprotein A-I protein |
| 04/22/2004 | US20040077064 Identification and isolation of novel DNA and to the recombinant production of novel polypeptides |
| 04/22/2004 | US20040076623 Biochemical immobilization, immobilized enzyme, resin peptides, for solid phase synthesis; a benzaldehyde polystyrene lantern, coupled to streptavid or horseradish peroxidase |
| 04/22/2004 | CA2499318A1 Peptide mediated synthesis of metallic and magnetic materials |
| 04/21/2004 | EP1409710A1 Nucleic acid and corresponding protein entitled 161p5c5 useful in treatment and detection of cancer |
| 04/21/2004 | CN1490357A Structural body containing polyhydroxy chain alkyl ester |
| 04/21/2004 | CN1146408C Novel poly(methylidene malonate) microspheres, preparation method and pharmaceutical compositions containing them |
| 04/20/2004 | US6723344 Useful as implantable devices and wound dressings as the matrix of the invention is designed to be used in conjunction with such devices to provide protracted and controlled release of growth factor, to promote wound healing |
| 04/20/2004 | CA2057792C Process for immobilization onto the surfaces of elisa plates of a compound carrier complex and for immunization |
| 04/15/2004 | WO2004031381A1 Peptide capable of binding to nanographite structures |
| 04/15/2004 | WO2004022630A3 Water-soluble polymer alkanals |
| 04/15/2004 | US20040072748 Methods and compositions for the treatment and prevention of Staphylococcus and other bacterial infections |
| 04/15/2004 | DE10246740A1 Catalyst composition, useful for metal-catalyzed reactions e.g. asymmetric hydrogenation, comprises protein and interacting catalytic unit that includes a transition metal |
| 04/14/2004 | EP1406927A2 Glycopeptides, their preparation and use in the diagnosis or therapeutic treatment of multiple sclerosis |
| 04/14/2004 | EP1406493A1 Administration of agents via the pept-2 transporter |
| 04/14/2004 | CN1145692C Hypersensitive response induced resistance in plants by seed treatment |
| 04/13/2004 | US6720161 Immobilized substrate, separation gels and method for detecting enzymatic activity |
| 04/13/2004 | US6719978 Virus-like particles for the induction of autoantibodies |
| 04/13/2004 | CA2291608C Neurotrophic factor receptors |
| 04/08/2004 | WO2004028473A2 Synergistic compositions for the prevention and treatment of acquired immunodeficiency syndrome |
| 04/08/2004 | US20040067521 Sequence specific recognition reagents (oligonucleotide, monoclonal antibodies) attached to a solid substrate; sequencing, fingerprinting and mapping biological polymers |
| 04/08/2004 | CA2498483A1 Synergistic compositions for the prevention and treatment of acquired immunodeficiency syndrome |
| 04/06/2004 | US6716964 CtIP, a novel protein that interacts with CtBP and uses therefor |
| 04/01/2004 | WO2003078454A3 Polymer supported reagents for natural products purification |
| 04/01/2004 | US20040062771 Clostridial toxin disease therapy |
| 03/31/2004 | EP1402075A1 Development of mutations useful for attenuating dengue viruses and chimeric dengue viruses |
| 03/31/2004 | EP1402064A2 Protein arrays and methods and systems for producing the same |
| 03/31/2004 | EP1402055A1 Method for producing a layer of functional molecules |
| 03/31/2004 | EP1401400A1 Porous matrix comprising cross-linked particles |
| 03/31/2004 | EP1401286A1 Method of inhibiting fungal growth |
| 03/31/2004 | CN1486328A Method for surface display of proteins on genetic carriers |
| 03/30/2004 | US6713296 Due to a deletion of at least 10 amino acids, neurovirulence is attenuated as compared to a naturally occurring varicella-zoster virus |
| 03/30/2004 | US6713281 Directed evolution of thermophilic enzymes |
| 03/25/2004 | WO2004024777A1 Hydroxyalkyl starch derivatives |
| 03/25/2004 | WO2004024776A1 Method of producing hydroxyalkyl starch derivatives |
| 03/25/2004 | WO2004024761A1 Hasylated polypeptides, especially hasylated erythropoietin |
| 03/25/2004 | WO2003085375A3 Hcv antiviral and cytotoxicity drug screening assay |
| 03/25/2004 | US20040058424 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 03/25/2004 | US20040058411 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 03/25/2004 | US20040058390 Contacting a polypeptide with an ester or thioester group, with an anchor molecule containing two nucleotphilic group at meta or ortho positions to each other, trans-esterification of ester/thiosester with nucleotphilic group |
| 03/25/2004 | CA2799437A1 Method of producing hydroxyalkyl starch derivatives |
| 03/25/2004 | CA2496318A1 Hydroxyalkyl starch derivatives |
| 03/25/2004 | CA2496317A1 Method of producing hydroxyalkyl starch derivatives |
| 03/25/2004 | CA2495242A1 Hasylated polypeptides, especially hasylated erythropoietin |
| 03/24/2004 | EP1400533A1 HASylated polypeptides, especially HASylated erythropoietin |
| 03/23/2004 | US6710168 Vancomycin derivatives |
| 03/23/2004 | US6709841 Generating preferential polypeptide; obtain cell, transform with vector coding preferential polypeptide, recover polypeptide |
| 03/23/2004 | US6709821 Polypeptides having a functional domain of interest and methods of identifying and using same |
| 03/18/2004 | WO2004022630A2 Water-soluble polymer alkanals |
| 03/18/2004 | US20040053358 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 03/18/2004 | US20040053340 Protein arrays |
| 03/18/2004 | US20040053298 Composition for polymerising immobilisation of biological molecules and method for producing said composition |
| 03/17/2004 | EP1398328A1 Hydroxyalkyl starch derivatives |
| 03/17/2004 | EP1398327A1 Method of producing hydroxyalkyl starch derivatives |
| 03/17/2004 | EP1398322A1 HASylated polypeptides, especially HASylated erythropoietin |
| 03/17/2004 | EP1397486A2 Polymorphisms in the human gene for cytochrome p450 polypeptide 2c8 and their use in diagnostic and therapeutic applications |
| 03/17/2004 | CN1142433C Process for preparing antigen microarray based on self antibody repertoire |
| 03/17/2004 | CN1142189C Device for producing macromolecule materials in form of porous polymer bead carrier and its preparing process and application |
| 03/16/2004 | US6706862 Backbone-cyclized BPI peptidomimetics |
| 03/16/2004 | US6706268 Human deficiency virus type-1 (HIV-1) peptide encoded by the VIF gene |
| 03/11/2004 | WO2004019967A1 Method for isolating subpopulations of proteins that engage in protein-protein interactions |
| 03/11/2004 | US20040049011 Novel synthetic peptides with antimicrobial and endotoxin neutralizing properties for management of the sepsis syndrome |
| 03/11/2004 | US20040048335 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 03/11/2004 | US20040048334 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 03/11/2004 | US20040048333 Membrane/fusion proteins; PRO polypeptides; immunoglobulins; solid phase synthesis; for modulating uptake of glucose by skeletal muscle cells |
| 03/11/2004 | CA2492324A1 Method for isolating subpopulations of proteins that engage in protein-protein interactions |
| 03/10/2004 | EP0885011B1 Diagnosis of autoimmune diseases of the inner ear based on the detection of myelin protein p zero |
| 03/10/2004 | EP0769955B1 Non-antigenic amine derived polymers and polymer conjugates |
| 03/09/2004 | US6703381 Administering amphiphilic enkephalin-oligomer conjugate |
| 03/04/2004 | WO2004018997A2 Methods and compositions for modulating amyloid beta |
| 03/04/2004 | WO2004004455A3 Composition and method for stabilising biomolecules |
| 03/04/2004 | WO2003055980A3 Il-17 like molecules and uses thereof |
| 03/04/2004 | WO2002081637A3 Peptides incorporating chemoselective functionalities |
| 03/03/2004 | EP1393750A2 Conjugates for treating an immune disease |
| 03/03/2004 | EP1392340A2 Cytotoxic peptides and peptidomimetics based thereon, and methods for use thereof |
| 02/26/2004 | WO2004016769A2 Antibodies directed to monocyte chemo-attractant protein-1 (mcp-1) and uses thereof |
| 02/26/2004 | WO2002083917A8 Nucleic acid and corresponding protein entitled 161p5c5 useful in treatment and detection of cancer |
| 02/26/2004 | US20040039201 Functionalized compositions for improved immobilization |
| 02/26/2004 | US20040039164 Invention relates to identification and isolation of novel DNA and to recombinant production of novel polypeptides |
| 02/26/2004 | US20040039116 A solid support comprising a diol group for bonding to oligonucleotides, proteins, cells, and coupling to substrate with a silane compound |
| 02/26/2004 | US20040038876 For use in therapy and diagnosis |
| 02/26/2004 | US20040038337 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 02/26/2004 | US20040038336 Identification and isolation of novel DNA and to the recombinant production of novel polypeptides |
| 02/26/2004 | US20040038335 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 02/26/2004 | US20040038268 Support bound probes and methods of analysis using the same |
| 02/26/2004 | DE10237517A1 Removing biomolecules from liquid media, useful for purification, product recovery or preparation of vectors, comprises retention on hydrotalcite of controlled porosity |
| 02/26/2004 | CA2496419A1 Antibodies directed to monocyte chemo-attractant protein-1 (mcp-1) and uses thereof |
| 02/25/2004 | EP1220868B1 Extracorporeal endotoxin removal method |
| 02/25/2004 | CN1477126A Long-acting growth hormone and medicine composition |
| 02/24/2004 | US6696275 Generating preferential polypeptide; obtain nucleotide sequences, mutate, express nucleotide sequences, separate and recover polypeptide |
| 02/19/2004 | US20040033576 Using crystalline cell surface protein for directed monomolecular bonding of molecular layers and/or their attachment to solid support; immobilized cells; micelles |
| 02/19/2004 | US20040033560 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 02/19/2004 | US20040033559 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 02/19/2004 | US20040033558 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 02/19/2004 | US20040033487 Comprises nucleotide sequences coding associated with glycosylation of viral structural polypeptides; prototype immunogens for treatment and prevention of viral disease; genetic vaccines |